SEC Company Response from enVVeno Medical (NVNO) — May 25, 2018
enVVeno Medical Corp
Date: May 25, 2018 · CIK: 0001661053 · Accession: 0001493152-18-007828
AI Filing Summary & Sentiment
File numbers found in text: 333-220372
Show Raw Text
CORRESP
1
filename1.htm
Network
1 Financial Securities, Inc.
2 Bridge Avenue, Suite 241
Red Bank, NJ 07701
May
25, 2018
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Amanda Ravitz
Re:
Hancock
Jaffe Laboratories, Inc.
Registration
Statement on Form S-1
File
No. 333-220372
Request
for Acceleration
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), we, as the sole
underwriter (the “Underwriter”), hereby join in the request of Hancock Jaffe Laboratories, Inc. (the “Registrant”),
for the acceleration of the effective date of the Registrant’s Registration Statement on Form S-1 (File No. 333-220372)
(as amended, the “Registration Statement”), relating to a public offering of shares of the Registrant’s units,
each unit consisting of one share of our common stock, par value $0.00001 per share, and a common stock purchase warrant to purchase
one share of the Registrant’s common stock, so that the Registration Statement may be declared effective on Wednesday,
May 30, 2018 at 4:30 p.m. Eastern Time, or as soon thereafter as practicable. The undersigned, as Representatives, confirms
that they are aware of their obligations under the Securities Act.
In
connection with the Registration Statement, pursuant to Rule 460 under the Securities Act, we wish to advise you that, between
May 22, 2018 and the date hereof, 250 copies of the Registrant’s Preliminary Prospectus, dated May 22, 2018,
were distributed to investors, prospective underwriters and dealers and others.
The
undersigned, as Representatives, hereby advise you that they have complied and will continue to comply, and that they have been
informed by the participating underwriters and dealers that they have complied and will comply, with the provisions of Rule 15c2-8
promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above proposed offering.
Very
truly yours,
NETWORK
1 FINANCIAL SECURITIES, INC.
Acting
severally on behalf of itself and the several underwriters
By:
NETWORK
1 FINANCIAL SECURITIES, INC.
By:
/s/
Damon Testaverde
Name:
Damon
Testaverde
Title:
Managing
Director